# Lusaris Therapeutics, Inc. — Form D

Lusaris Therapeutics, Inc. of Morrisville, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-06. The offering totals $60.2M, of which $60.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-12-06
- Form: D
- Accession: 0001953017-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $60.2M
- Amount sold: $60.2M
- Investors: 9
- Date of first sale: 2022-10-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466642

## Issuer

- Name: Lusaris Therapeutics, Inc.
- CIK: 0001953017
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 630 Davis Drive, Suite 220, Morrisville, NC, 27560
- Phone: 617-778-2500

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| DANIEL GRAU | Director | WALTHAM, MA |
| Andrew Levin | Director | BOSTON, MA |
| Edward Monaghan | Director | Morrisville, NC |
| Neil Buckley | Executive Officer | Boston, MA |
| Ramin Farzaneh-Far | Executive Officer | San Diego, CA |
| Andrew Levin | Executive Officer | BOSTON, MA |
| Edward Monaghan | Executive Officer | Morrisville, NC |
| CATHERINE RIESEN | Executive Officer | WALTHAM, MA |
| Edward Monaghan | Promoter | Morrisville, NC |

## More

- [CIK 1953017 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1953017&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001953017-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.